West Nile Virus Mortality in the US: Trends, Risk Factors & Surveillance

West Nile virus (WNV) — leading cause of mosquito-borne disease in continental US — shows variable annual mortality since 1999 introduction.

Annual Death Trends (CDC Data)

  • 10-year average (2014–2023): ~130 deaths/year.
  • Range: 28 (2012) to 286 (2012 — corrected: 286 was 2012 peak; 2018 had 167).
  • Peak years: 2002 (284), 2012 (286), 2003 (264) — correlated with hot, dry summers amplifying Culex vectors.
  • Recent (2020–2023): 70–120 range; climate variability drives fluctuations.

Risk Factors for Fatal Outcome

  • Age >60: 90% of deaths; immunosenescence, comorbidities.
  • Neuroinvasive disease: Encephalitis, meningitis, acute flaccid paralysis (AFP) — 1 in 150 infections.
  • Immunocompromise: Transplant, HIV, malignancy, steroids.
  • Comorbidities: Diabetes, hypertension, CKD, CVD.
  • Male sex: 1.5–2× higher neuroinvasive incidence.

Clinical Spectrum

  • Asymptomatic: 80%.
  • West Nile fever (self-limited febrile illness): 20%.
  • Neuroinvasive: <1% — case-fatality 10–15% (higher in elderly).

Surveillance & Prevention

  • ArboNET: National passive reporting (human, veterinary, mosquito, avian).
  • Vector control: Larviciding, adulticiding, source reduction.
  • Personal protection: DEET, picaridin, permethrin-treated clothing, dawn/dusk avoidance.
  • Blood donation screening: Nucleic acid testing since 2003.

No human vaccine. Mortality concentrated in elderly with neuroinvasive disease. Climate change may expand geographic range and season length.

Viral Infections - Related Articles